Drug Guide

Generic Name

Acrivastine; Pseudoephedrine Hydrochloride

Brand Names Semprex-D

Classification

Therapeutic: Allergy and Cold Relief

Pharmacological: Histamine H1 Antagonist and Sympathomimetic

FDA Approved Indications

  • Relief of nasal congestion, sneezing, and runny nose due to allergies or cold

Mechanism of Action

Acrivastine, an H1 antihistamine, blocks histamine receptors to reduce allergy symptoms; Pseudoephedrine is a decongestant that stimulates adrenergic receptors in nasal mucosa, causing vasoconstriction and decreasing swelling.

Dosage and Administration

Adult: Typically, 8 mg of acrivastine with 60 mg of pseudoephedrine every 4-6 hours as needed, not exceeding 4 doses in 24 hours.

Pediatric: Consult specific product guidelines; generally not recommended for children under 12 without physician oversight.

Geriatric: Adjust dosage as per clinical response; increased caution due to potential cardiovascular effects.

Renal Impairment: Use with caution; dose adjustment may be necessary.

Hepatic Impairment: Use with caution; monitor for reduced clearance.

Pharmacokinetics

Absorption: Well absorbed orally.

Distribution: Widely distributed; peak levels in 1-2 hours.

Metabolism: Metabolized in the liver (pseudoephedrine minimally metabolized).

Excretion: Excreted primarily in urine.

Half Life: Acrivastine approximately 20-24 hours; pseudoephedrine approximately 4-6 hours.

Contraindications

  • Allergy to any component of the drug.
  • Use of monoamine oxidase inhibitors (MAOIs) within the past 14 days.

Precautions

  • History of hypertension, heart disease, or glaucoma.
  • Use caution in elderly and patients with urinary retention or thyroid disease.

Adverse Reactions - Common

  • Drowsiness, dry mouth, dizziness (Common)
  • Nervousness, insomnia (Less common)

Adverse Reactions - Serious

  • Hypertension, tachycardia, arrhythmias (Rare)
  • Allergic reactions including rash, urticaria (Rare)

Drug-Drug Interactions

  • Monoamine oxidase inhibitors (MAOIs), other sympathomimetics, CNS depressants

Drug-Food Interactions

N/A

Drug-Herb Interactions

N/A

Nursing Implications

Assessment: Monitor for adverse reactions such as hypertension, nervousness, or sedation.

Diagnoses:

  • Ineffective airway clearance related to nasal congestion.
  • Risk for hypertension due to pseudoephedrine.

Implementation: Administer with food to minimize gastrointestinal upset. Monitor cardiovascular status.

Evaluation: Assess relief of nasal congestion and allergy symptoms.

Patient/Family Teaching

  • Take medication exactly as prescribed.
  • Avoid operating heavy machinery until response is known.
  • Be aware of possible side effects such as dizziness or nervousness.
  • Tell your doctor if you experience palpitations or hypertension.

Special Considerations

Black Box Warnings:

  • Pseudoephedrine can increase blood pressure and cause cardiovascular events, caution in hypertensive patients.

Genetic Factors: Precautions in patients with genetic predispositions to drug sensitivities.

Lab Test Interference: May interfere with certain urinary assays.

Overdose Management

Signs/Symptoms: Severe hypertension, tachycardia, agitation, seizures.

Treatment: Supportive care; control blood pressure; activated charcoal if recent ingestion; consider dialysis in severe cases.

Storage and Handling

Storage: Store at room temperature away from light and moisture.

Stability: Stable for 2-3 years when unopened.

This guide is for educational purposes only and is not intended for clinical use.